SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-041267
Filing Date
2021-08-10
Accepted
2021-08-10 09:05:15
Documents
2
Period of Report
2021-08-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea145446-8k_virpaxpharma.htm 8-K 17238
2 VIRPAX PHARMACEUTICALS REPORTS 2021 SECOND QUARTER RESULTS AND RECENT DEVELOPMEN ea145446ex99-1_virpaxpharma.htm EX-99.1 80306
  Complete submission text file 0001213900-21-041267.txt   98796
Mailing Address 1554 PAOLI PIKE #279 WEST CHESTER PA 19380
Business Address 1554 PAOLI PIKE #279 WEST CHESTER PA 19380 484-875-3195
Virpax Pharmaceuticals, Inc. (Filer) CIK: 0001708331 (see all company filings)

IRS No.: 821510982 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40064 | Film No.: 211158619
SIC: 2834 Pharmaceutical Preparations